# Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe

> **NCT04935255** · — · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Testicular Cancer

## Interventions

- **OTHER:** Blood sampling - Pharmacokinetic assessment

## Key facts

- **NCT ID:** NCT04935255
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-11
- **Primary completion:** 2022-06-23
- **Final completion:** 2022-06-23
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04935255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04935255, "Determining the Clinical Relevance of the inTeraction Between AprepitaNt aNd EtoposiDe". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04935255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*